Home Newsfeeds Citigroup Maintains Buy on Interpublic Gr of Cos, Lowers Price Target to $33

Citigroup Maintains Buy on Interpublic Gr of Cos, Lowers Price Target to $33

Citigroup analyst Jason Bazinet maintains Interpublic Gr of Cos (NYSE:IPG) with a Buy and lowers the price target from $43 to $33.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Citigroup analyst Jason Bazinet maintains Interpublic Gr of Cos (NYSE:IPG) with a Buy and lowers the price target from $43 to $33.

Cramer Gushes Over Nvidia’s Q1 Print, CEO Jensen Huang: ‘Loved It, Love Him And His Team’

By Shanthi Rexaline

May 25, 1:50 AM

Nvidia Corp. (NASDAQ:NVDA) reported stellar quarterly results that ticked every box, and investors promptly sent its shares solidly…

NVDA

TD Securities Initiates Coverage On Thinkific Labs with Hold Rating, Announces Price Target of $2.75

By Benzinga Newsdesk

September 13, 1:17 PM

TD Securities analyst Daniel Chan initiates coverage on Thinkific Labs (OTC:THNCF) with a Hold rating and announces Price Target of $2.75.

THNCF

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today

By Benzinga Insights

February 10, 4:01 PM

Merck & Co (NYSE:MRK) has outperformed the market over the past 5 years by 6.82% on an annualized…

MRK

New Study Evaluates The Use Of Masimo PVi As An Indicator Of Fluid Responsiveness To Guide Goal-Directed Fluid Therapy In Adult Neurosurgical Patients

By Happy Mohamed

March 6, 11:31 AM

Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line Masimo (NASDAQ:MASI) today

MASI

Citigroup Maintains Buy on Interpublic Gr of Cos, Lowers Price Target to $33

Related Posts

Cramer Gushes Over Nvidia’s Q1 Print, CEO Jensen Huang: ‘Loved It, Love Him And His Team’

TD Securities Initiates Coverage On Thinkific Labs with Hold Rating, Announces Price Target of $2.75

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today

New Study Evaluates The Use Of Masimo PVi As An Indicator Of Fluid Responsiveness To Guide Goal-Directed Fluid Therapy In Adult Neurosurgical Patients